Determination of levodopa and benserazide hydrochloride in pharmaceutical formulations by CZE with amperometric detection

Chromatographia

Volumn 61, Issue 5-6, 2005, Pages 265-270

  Wang, J ^a,b   Zhou, Y ^a   Liang, J ^a   He, P G ^a   Fang, Y Z ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE FOR FOOD AND DRUG CONTROL   (China)

Author keywords

Amperometric detection; Benserazide and (R,S) 2 amino 3 hydroxypropanohydrazide; Capillary electrophoresis; Co beneldopa pharmaceutical formulations; Levodopa

Indexed keywords

2 AMINO 3 HYDROXYPROPANOHYDRAZIDE; BENSERAZIDE; BENSERAZIDE PLUS LEVODOPA; BUFFER; HYDRAZIDE DERIVATIVE; LEVODOPA; PHOSPHATE; UNCLASSIFIED DRUG;

AMPEROMETRY; ARTICLE; CAPILLARY ELECTROPHORESIS; CORRELATION COEFFICIENT; DRUG DETERMINATION; DRUG EFFICACY; DRUG FORMULATION; DRUG IMPURITY; DRUG SENSITIVITY; ELECTRIC POTENTIAL; ELECTRODE; PH; PRIORITY JOURNAL; SAMPLING; TABLET;

EID: 16444380853     PISSN: 00095893     EISSN: None     Source Type: Journal    
DOI: 10.1365/s10337-005-0515-x     Document Type: Article

References (27)

1. Calne DB, Sandler M (1970) Nature 226:21-24
2. British Pharmaceutical Codex (1973) The Pharmaceutical Press, Bloomsbury
3. Chose K (1985) Drugs Today 10:463-471
4. Sweetman SC (ed) (2002) Martindale - the complete drug reference, 33rd edn. Pharmaceutical Press, London, UK, p 1160
5. State Food and Drug Administration of P.R. China (1999) JX 19990140: Import specification of co-beneldopa granules, China, pp 581-582
6. British Pharmacopoeia (2004) Co-beneldopa capsules. Stationery Office, London, UK, pp 2303-2305
7. British Pharmacopoeia (2004) Dispersible Co-beneldopa tablets. Stationery Office, London, UK, pp 2305-2306
8. Fanali S, Pucci V, Sabbioni C, Reggi MA (2000) Electrophoresis 21:2432-2437
9. Uslu B, Ozkan SA (2002) Anal Lett 35(2):303-314
10. Coello J, Maspoch S, Villegas N (2000) Talanta 53:627-637
11. Hassib ST (1990) Anal Lett 23:2195-2214
12. Hassib ST, El-Khateeb SZ (1990) Anal Lett 23:255-271
13. Fu CG, Song LN, Fang YZ (1999) Anal Chini Acta 399:259-263
14. You TY, Yang XR, Wang EK (1999) Anal Chim Acta 401:29-34
15. Wang AF, Zhou Y, Wang F, He PG, Fang YZ (2004) J Pharm Biomed Anal 35:959-964
16. Zhang L, Chen GN, Hu Q, Fang YZ (2001) Anal Chim Acta 431:287-292
17. Zhou TS, Hu Q, Yu H, Fang YZ (2001) Anal Chim Acta 441:23-28
18. Zhang LY, Qv SF, Wang ZL, Cheng JK (2003) J Chromatogr B 792:381-385
19. Chu QC, Cao YH, Peng YY, Fu L, Ye JN (2004) Chromatographia 60:125-130
20. Chen G, Luo HF, Ye JN, Hu CQ (2001) Talanta 54:1067-1076
21. Fang YZ, Fang XM, Ye JN (1995) Chem J Univ 16:1514-1517
22. Fu CG, Song LN, Fans YZ (1998) Anal Chim Acta 37:181-187
23. Zhou TS, Yu H, Hu Q, Fang YZ (2002) Pharm Biomed Anal 20:13-19
24. Gomez R, Hagel RB, MacMullan EA (1976) Anal Profiles Drug Subs 5:189-223
25. Schwartz DE, Brandt R (1978) Arzneimittelforschung 28:302-307
26. United States Pharmacopeial Convention (2004) Validation of compendial methods. In: US Pharmacopoeia, 27th edn. The United States Pharmacopeial Convention, MD, USA, pp 2622-2625
27. Hartmann C, Massart DL, McDowall RD (1994) J Pharm Biomed Anal 12(11):1337-1343